AC
MNTA

Athanor Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Athanor Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-41,048
Closed -$2.15M – 872
2020
Q3 		$2.15M Buy
41,048
+25,716
+168% +$1.06M 0.08% 132
2020
Q2 		$510K Buy
+15,332
New +$488K 0.03% 301

Athanor Capital's MNTA Position: Q4 2020 in Review

Athanor Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 41,048 shares — an estimated $2.15M sold.

Athanor Capital first reported a position in MNTA in Q2 2020 and held it in 2 quarters. The position peaked at $2.15M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Athanor Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Athanor Capital sold 41,048 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.15M.
  • Athanor Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2020 and held it in 2 quarters.
  • Athanor Capital's Momenta Pharmaceuticals, Inc. position peaked at $2.15M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.